Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


29.05.2017

1 Alzheimer Dis Assoc Disord
2 Biochemistry
1 BMC Neurol
1 Brain Res
1 Curr Alzheimer Res
1 Dement Geriatr Cogn Disord
1 Exp Gerontol
1 J Neurochem
1 J Neurol Neurosurg Psychiatry
1 Lancet Neurol
1 MMWR Morb Mortal Wkly Rep
1 Nat Rev Neurol
2 Neurobiol Aging
1 Neuroscience
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. KOENIG AM, Mechanic-Hamilton D, Xie SX, Combs MF, et al
    Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study.
    Alzheimer Dis Assoc Disord. 2017;31:107-113.
    PubMed     Text format     Abstract available


    Biochemistry

  2. KANURU M, Aradhyam GK
    Chaperone-like Activity of Calnuc Prevents Amyloid Aggregation.
    Biochemistry. 2017;56:149-159.
    PubMed     Text format     Abstract available

  3. KUROCHKIN IV, Guarnera E, Wong JH, Eisenhaber F, et al
    Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
    Biochemistry. 2017;56:228-239.
    PubMed     Text format     Abstract available


    BMC Neurol

  4. LANE CA, Parker TD, Cash DM, Macpherson K, et al
    Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development.
    BMC Neurol. 2017;17:75.
    PubMed     Text format     Abstract available


    Brain Res

  5. JANG WY, Lee BR, Jeong J, Sung Y, et al
    Overexpression of serum amyloid a 1 induces depressive-like behavior in mice.
    Brain Res. 2017;1654.
    PubMed     Text format     Abstract available


    Curr Alzheimer Res

  6. WAMS EJ, Wilcock GK, Foster RG, Wulff K, et al
    Sleep-wake patterns and cognition of older adults with amnestic mild cognitive impairment (aMCI): A comparison with cognitively healthy adults and moderate Alzheimer's disease patients.
    Curr Alzheimer Res. 2017 May 22. doi: 10.2174/1567205014666170523095634.
    PubMed     Text format     Abstract available


    Dement Geriatr Cogn Disord

  7. ZHONG X, Shi H, Hou L, Chen B, et al
    Neuropsychiatric Features of Neurosyphilis: Frequency, Relationship with the Severity of Cognitive Impairment and Comparison with Alzheimer Disease.
    Dement Geriatr Cogn Disord. 2017;43.
    PubMed     Text format     Abstract available


    Exp Gerontol

  8. KWON Y
    Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease.
    Exp Gerontol. 2017 May 17. pii: S0531-5565(17)30214.
    PubMed     Text format     Abstract available


    J Neurochem

  9. TSE KH, Herrup K
    Re-imagining Alzheimer's disease - the diminishing importance of amyloid and a glimpse of what lies ahead.
    J Neurochem. 2017 May 26. doi: 10.1111/jnc.14079.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  10. LEMSTRA AW, de Beer MH, Teunissen CE, Schreuder C, et al
    Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies.
    J Neurol Neurosurg Psychiatry. 2017;88:113-118.
    PubMed     Text format     Abstract available


    Lancet Neurol

  11. IRWIN DJ, Grossman M, Weintraub D, Hurtig HI, et al
    Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Lancet Neurol. 2017;16:55-65.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  12. TAYLOR CA, Greenlund SF, McGuire LC, Lu H, et al
    Deaths from Alzheimer's Disease - United States, 1999-2014.
    MMWR Morb Mortal Wkly Rep. 2017;66:521-526.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  13. WOOD H
    Alzheimer disease: Peripheral Abeta clearance - a therapeutic strategy for AD?
    Nat Rev Neurol. 2017 May 26. doi: 10.1038/nrneurol.2017.
    PubMed     Text format    


    Neurobiol Aging

  14. GALLO M, Frangipane F, Cupidi C, De Bartolo M, et al
    The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family.
    Neurobiol Aging. 2017 Apr 27. pii: S0197-4580(17)30145.
    PubMed     Text format     Abstract available

  15. PARK J, An SSA, Giau VV, Shim K, et al
    Identification of a novel PSEN1 mutation (Leu232Pro) in a Korean patient with early-onset Alzheimer's disease and a family history of dementia.
    Neurobiol Aging. 2017 Apr 26. pii: S0197-4580(17)30133.
    PubMed     Text format     Abstract available


    Neuroscience

  16. QIU WQ
    Amylin and its G-protein-coupled receptor: a probable pathological process and drug target for Alzheimer's disease.
    Neuroscience. 2017 May 18. pii: S0306-4522(17)30349.
    PubMed     Text format     Abstract available


    PLoS One

  17. FANG J, Wang L, Li Y, Lian W, et al
    AlzhCPI: A knowledge base for predicting chemical-protein interactions towards Alzheimer's disease.
    PLoS One. 2017;12:e0178347.
    PubMed     Text format     Abstract available

  18. LV F, Yang X, Cui C, Su C, et al
    Exogenous expression of Drp1 plays neuroprotective roles in the Alzheimer's disease in the Abeta42 transgenic Drosophila model.
    PLoS One. 2017;12:e0176183.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: